Alnylam Pharmaceuticals is a biopharmaceutical company based in Cambridge, Massachusetts, in the United States. It develops medicines that use RNA interference, a natural cellular process that silences specific genes, to treat serious diseases. Its products include treatments for hereditary transthyretin-mediated amyloidosis and acute hepatic porphyria, and it also works on therapies for other rare and genetic conditions. Its customers are mainly hospitals, specialist physicians and patients in markets around the world.
Alnylam Pharmaceuticals, Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1LN34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1353 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
9/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-24.7%
From 52-week high-56.9%
MomentumWeak
9/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-15.8%
6-month return-27.0%
12-month, skipping last month-52.4%
Stability (higher is calmer)Weak
18/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)58.4%
Worst drawdown, 1 year (smaller is calmer)-61.9%
LiquidityFair
57/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.07M BRL
Zero-volume days21.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 50.25 – 131.80Daily closes, split-adjusted
Signals
50-day average61.48
200-day average75.36
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.33
Technical summary
Daily
Strongly bearish
0 bullish · 4 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
57.79
Bearish
EMA 10
58.31
Bearish
SMA 20
59.95
Bearish
EMA 20
59.39
Bearish
SMA 50
61.48
Bearish
EMA 50
61.78
Bearish
SMA 100
65.99
Bearish
EMA 100
66.21
Bearish
SMA 200
75.36
Bearish
EMA 200
74.22
Bearish
Oscillators (daily)
RSI (14)
39.37
Neutral
MACD (12, 26)
-1.40
Bearish
Momentum (12)
-1.24
Bearish
Stochastic %K (14)
22.55
Neutral
Williams %R (14)
-77.45
Neutral
CCI (20)
-59.95
Neutral
Pivot points (classic, last session)
S3
55.80
S2
56.28
S1
56.53
Pivot
57.01
R1
57.26
R2
57.74
R3
57.99
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
